{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:27:02Z","timestamp":1794493622749,"version":"4.9.1"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/nrneurol.2009.62","type":"journal-article","created":{"date-parts":[[2009,6,5]],"date-time":"2009-06-05T08:12:59Z","timestamp":1244189579000},"page":"331-342","source":"Crossref","is-referenced-by-count":288,"title":["Hallucinations in Parkinson disease"],"prefix":"10.1038","volume":"5","author":[{"given":"Nico J.","family":"Diederich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"F\u00e9nelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Stebbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrneurol200962_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1212\/01.wnl.0000191325.31068.c4","volume":"66","author":"G F\u00e9nelon","year":"2006","unstructured":"F\u00e9nelon, G., Goetz, C. G. & Karenberg, A. Hallucinations in Parkinson disease in the prelevodopa era. Neurology 66, 93\u201398 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1176\/ajp.135.6.669","volume":"135","author":"C Moskovitz","year":"1978","unstructured":"Moskovitz, C., Moses, H. 3rd & Klawans, H. L. Levodopa induced psychosis: a kindling phenomenon. Am. J. Psychiatry 135, 669\u2013675 (1978).","journal-title":"Am. J. Psychiatry"},{"key":"BFnrneurol200962_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jns.2006.05.025","volume":"248","author":"M Onofrj","year":"2006","unstructured":"Onofrj, M. et al. Visual hallucinations in Parkinson's disease: clues to separate origins. J. Neurol. Sci. 248, 143\u2013150 (2006).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol200962_CR4","volume-title":"Paralysis Agitans. A Clinical and Genetic Study","author":"H Mj\u00f6nes","year":"1949","unstructured":"Mj\u00f6nes, H. Paralysis Agitans. A Clinical and Genetic Study (Ejnar Munksgaard, Copenhagen, 1949)."},{"key":"BFnrneurol200962_CR5","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1176\/ajp.107.12.901","volume":"107","author":"RS Schwab","year":"1951","unstructured":"Schwab, R. S., Fabing, H. D. & Prichard, J. S. Psychiatric symptoms and syndromes in Parkinson's disease. Am. J. Psychiatry 107, 901\u2013907 (1951).","journal-title":"Am. J. Psychiatry"},{"key":"BFnrneurol200962_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1212\/WNL.22.5.516","volume":"22","author":"OW Sacks","year":"1972","unstructured":"Sacks, O. W., Kohl, M. S., Messeloff, C. R. & Schwartz, W. F. Effects of levodopa in parkinsonian patients with dementia. Neurology 22, 516\u2013519 (1972).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR7","first-page":"577","volume":"33","author":"GG Celesia","year":"1972","unstructured":"Celesia, G. G. & Wanamaker, W. M. Psychiatric disturbances in Parkinson's disease. Dis. Nerv. Syst. 33, 577\u2013583 (1972).","journal-title":"Dis. Nerv. Syst."},{"key":"BFnrneurol200962_CR8","first-page":"419","volume":"80","author":"CG Goetz","year":"1999","unstructured":"Goetz, C. G. Hallucinations in Parkinson's disease: the clinical syndrome. Adv. Neurol. 80, 419\u2013423 (1999).","journal-title":"Adv. Neurol."},{"key":"BFnrneurol200962_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.7326\/0003-4819-111-3-218","volume":"111","author":"WE Golden","year":"1989","unstructured":"Golden, W. E., Lavender, R. C. & Metzer, E. S. Acute postoperative confusion and hallucinations in Parkinson's disease. Ann. Intern. Med. 111, 218\u2013222 (1989).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneurol200962_CR10","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","volume":"68","author":"CF Lippa","year":"2007","unstructured":"Lippa, C. F. et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68, 812\u2013819 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/01.JGP.0000192480.89813.80","volume":"14","author":"UP Mosimann","year":"2006","unstructured":"Mosimann, U. P. et al. Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies. Am. J. Geriatr. Psychiatry 14, 153\u2013160 (2006).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"BFnrneurol200962_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1055\/s-2000-11619","volume":"68","author":"NJ Diederich","year":"2000","unstructured":"Diederich, N. J., Pieri, V. & Goetz, C. G. Visual hallucinations in Parkinson and Charles Bonnet Syndrome patients. A phenomenological and pathogenetic comparison [German]. Fortschr. Neurol. Psychiat. 68, 129\u2013136 (2000).","journal-title":"Fortschr. Neurol. Psychiat."},{"key":"BFnrneurol200962_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/jnnp.70.6.727","volume":"70","author":"J Barnes","year":"2001","unstructured":"Barnes, J. & David, A. S. Visual hallucinations in Parkinson's disease: a review and phenomenlogical survey. J. Neurol. Neurosurg. Psychiatry 70, 727\u2013733 (2001).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200962_CR14","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/jnnp.70.6.734","volume":"70","author":"S Holroyd","year":"2001","unstructured":"Holroyd, S., Currie, L. & Wooten, G. F. Prospective study of hallucinations and delusions in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 70, 734\u2013738 (2001).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200962_CR15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/brain\/123.4.733","volume":"123","author":"G F\u00e9nelon","year":"2000","unstructured":"F\u00e9nelon, G., Mahieux, F., Huon, R. & Zi\u00e9gler, M. Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors. Brain 123, 733\u2013745 (2000).","journal-title":"Brain"},{"key":"BFnrneurol200962_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/jnnp.63.4.434","volume":"63","author":"JM Graham","year":"1997","unstructured":"Graham, J. M., Gr\u00fcnewald, R. A. & Sagar, H. J. Hallucinosis in idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 63, 434\u2013440 (1997).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200962_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/jnnp.64.4.533","volume":"64","author":"R Inzelberg","year":"1998","unstructured":"Inzelberg, R., Kipervasser, S. & Korczyn, A. D. Auditory hallucinations in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 64, 533\u2013535 (1998).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200962_CR18","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00415-002-0908-9","volume":"249","author":"G F\u00e9nelon.","year":"2002","unstructured":"F\u00e9nelon. G., Thobois, S., Bonnet, A. M., Broussolle, E. & Tison, F. Tactile hallucinations in Parkinson's disease. J. Neurol. 249, 1699\u20131703 (2002).","journal-title":"J. Neurol."},{"key":"BFnrneurol200962_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/01.wnf.0000180228.77802.32","volume":"28","author":"K Chou","year":"2005","unstructured":"Chou, K. et al. Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments. Clin. Neuropharmacol. 28, 215\u2013219 (2005).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol200962_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/mds.20701","volume":"21","author":"CG Goetz","year":"2006","unstructured":"Goetz, C. G., Wuu, J., Curgian, L. & Leurgans, S. Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients. Mov. Disord. 21, 267\u2013270 (2006).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1212\/01.WNL.0000129843.15756.A3","volume":"63","author":"L Marsh","year":"2004","unstructured":"Marsh, L. et al. Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology 63, 293\u2013300 (2004).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s00415-006-0388-4","volume":"254","author":"G Kiziltan","year":"2007","unstructured":"Kiziltan, G., Ozekmek\u00e7i, S., Ertan, S., Ertan, T. & Ergin\u00f6z, E. Relationship between age and subtypes of psychotic symptoms in Parkinson's disease. J. Neurol. 254, 448\u2013452 (2007).","journal-title":"J. Neurol."},{"key":"BFnrneurol200962_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1212\/01.WNL.0000148479.10865.FE","volume":"64","author":"CG Goetz","year":"2005","unstructured":"Goetz, C. G., Wuu, J., Curgian, L. M. & Leurgans, S. Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology 64, 81\u201386 (2005).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/mds.21864","volume":"23","author":"J Pagonabarraga","year":"2008","unstructured":"Pagonabarraga, J. et al. A prospective study of delusional misidentification syndromes in Parkinson's disease with dementia. Mov. Disord. 23, 443\u2013448 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/mds.21382","volume":"22","author":"B Ravina","year":"2007","unstructured":"Ravina, B. et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov. Disord. 22, 1061\u20131068 (2007).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR26","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1212\/01.wnl.0000215428.46057.3d","volume":"66","author":"JM Miyasaki","year":"2006","unstructured":"Miyasaki, J. M. et al. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66, 996\u20131002 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR27","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/mds.21875","volume":"23","author":"HH Fernandez","year":"2008","unstructured":"Fernandez, H. H. et al. Scales to assess psychosis in Parkinson's disease: critique and recommendations. Mov. Disord. 23, 484\u2013500 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR28","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR29","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1136\/jnnp.2007.124677","volume":"79","author":"DR Williams","year":"2008","unstructured":"Williams, D. R., Warren, J. D. & Lees, A. J. Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism. J. Neurol. Neurosurg. Psychiatry 79, 652\u2013655 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200962_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/gps.930100608","volume":"10","author":"HC Haeske-Dewick","year":"1995","unstructured":"Haeske-Dewick, H. C. Hallucinations in Parkinson's disease: characteristics and associated features. Int. J. Geriatr. Psych. 10, 487\u2013495 (1995).","journal-title":"Int. J. Geriatr. Psych."},{"key":"BFnrneurol200962_CR31","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1001\/archneur.56.5.595","volume":"56","author":"D Aarsland","year":"1999","unstructured":"Aarsland, D., Larsen, J. P., Cummins, J. L. & Laake, K. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease. A community-based study. Arch. Neurol. 56, 595\u2013601 (1999).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol200962_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1212\/01.wnl.0000265593.34438.00","volume":"69","author":"KM Biglan","year":"2007","unstructured":"Biglan, K. M., Holloway, R. G. Jr, McDermott, M. P., Richard, I. H. & Parkinson Study Group CALM-PD Investigators. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology 69, 187\u2013195 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely, M. A., Reid, W. G., Adena, M. A., Halliday, G. M. & Morris, J. G. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov. Disord. 23, 837\u2013844 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR34","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1212\/WNL.57.11.2078","volume":"57","author":"CG Goetz","year":"2001","unstructured":"Goetz, C. G., Leurgans, S., Pappert, E. J., Raman, R. & Stemer, A. B. Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology 57, 2078\u20132082 (2001).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/archneur.63.5.713","volume":"63","author":"CG Goetz","year":"2006","unstructured":"Goetz, C. G., Fan, W., Leurgans, S., Bernard, B. & Stebbins, G. T. The malignant course of \u201cbenign hallucinations\u201d in Parkinson disease. Arch. Neurol. 63, 713\u2013716 (2006).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol200962_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.parkreldis.2007.05.009","volume":"14","author":"A McKinlay","year":"2008","unstructured":"McKinlay, A. et al. A profile of neuropsychiatric problems and their relationship to quality of lifefor PD patients without dementia. Parkinsonism Relat. Disord. 14, 37\u201342 (2008).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol200962_CR37","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1212\/WNL.43.11.2227","volume":"43","author":"CG Goetz","year":"1993","unstructured":"Goetz, C. G. & Stebbins, G. T. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 43, 2227\u20132229 (1993).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR38","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1532-5415.2000.tb06891.x","volume":"48","author":"D Aarsland","year":"2000","unstructured":"Aarsland, D., Larsen, J. P., Tandberg, E. & Laake, K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J. Am. Geriatr. Soc. 48, 938\u2013942 (2000).","journal-title":"J. Am. Geriatr. Soc."},{"key":"BFnrneurol200962_CR39","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1212\/01.WNL.0000068010.82167.CF","volume":"60","author":"SA Factor","year":"2003","unstructured":"Factor, S. A. et al. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 60, 1756\u20131761 (2003).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR40","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/mds.20216","volume":"19","author":"P Hobson","year":"2004","unstructured":"Hobson, P. & Meara, J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov. Disord. 19, 1043\u20131049 (2004).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR41","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1212\/01.wnl.0000242630.52203.8f","volume":"67","author":"JE Galvin","year":"2006","unstructured":"Galvin, J. E., Pollack, J. & Morris, J. C. Clinical phenotype of Parkinson disease dementia. Neurology 67, 1605\u20131611 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR42","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00702-004-0209-9","volume":"111","author":"D Merims","year":"2004","unstructured":"Merims, D. et al. Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease. J. Neural Transm. 111, 1447\u20131453 (2004).","journal-title":"J. Neural Transm."},{"key":"BFnrneurol200962_CR43","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/archneur.1996.00550120077019","volume":"53","author":"JR Sanchez-Ramos","year":"1996","unstructured":"Sanchez-Ramos, J. R., Ortoll, R. & Paulson, G. W. Visual hallucinations associated with Parkinson's disease. Arch. Neurol. 53, 1265\u20131268 (1996).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol200962_CR44","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1212\/WNL.50.2.515","volume":"50","author":"CG Goetz","year":"1998","unstructured":"Goetz, C. G. et al. Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations. Neurology 50, 515\u2013517 (1998).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR45","doi-asserted-by":"crossref","unstructured":"Baker, W. L. et al. Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis. Parkinsonism Relat. Disord. doi:10.1016\/j.parkreldis.2008.07.004 (2008).","DOI":"10.1016\/j.parkreldis.2008.07.004"},{"key":"BFnrneurol200962_CR46","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1176\/ajp.139.11.1526","volume":"139","author":"CG Goetz","year":"1982","unstructured":"Goetz, C. G., Tanner, C. M. & Klawans, H. L. Pharmacology of hallucinations induced by long-term drug therapy. Am. J. Psych. 139, 494\u2013497 (1982).","journal-title":"Am. J. Psych."},{"key":"BFnrneurol200962_CR47","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/j.1471-4159.1990.tb03162.x","volume":"55","author":"EK Perry","year":"1990","unstructured":"Perry, E. K. et al. Evidence of a monoaminergic- cholinergic imbalance related to visual hallucinations in Lewy Body Dementia. J. Neurochem. 55, 1454\u20131456 (1990).","journal-title":"J. Neurochem."},{"key":"BFnrneurol200962_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/brain\/awf033","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding, A. J., Broe, G. A. & Halliday, G. M. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125, 391\u2013403 (2002).","journal-title":"Brain"},{"key":"BFnrneurol200962_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00002093-199040200-00003","volume":"4","author":"EK Perry","year":"1990","unstructured":"Perry, E. K. et al. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis. Assoc. Disord. 4, 87\u201395 (1990).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"BFnrneurol200962_CR50","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/1531-8249(200012)48:6<868::AID-ANA7>3.0.CO;2-0","volume":"48","author":"C Ballard","year":"2000","unstructured":"Ballard, C. et al. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann. Neurol. 48, 868\u2013876 (2000).","journal-title":"Ann. Neurol."},{"issue":"Suppl. 17","key":"BFnrneurol200962_CR51","doi-asserted-by":"publisher","first-page":"S351","DOI":"10.1002\/mds.21683","volume":"22","author":"PT Francis","year":"2007","unstructured":"Francis, P. T. & Perry, E. K. Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. Mov. Disord. 22 (Suppl. 17), S351\u2013S357 (2007).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR52","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1006\/brcg.1995.1255","volume":"28","author":"EK Perry","year":"1995","unstructured":"Perry, E. K. & Perry, R. H. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn. 28, 240\u2013258 (1995).","journal-title":"Brain Cogn."},{"key":"BFnrneurol200962_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1006\/brcg.1998.1035","volume":"38","author":"M Sarter","year":"1998","unstructured":"Sarter, M. & Bruno, J. P. Cortical acetylcholine, reality distortion, schizophrenia, and Lewy Body Dementia: too much or too little cortical acetylcholine? Brain Cogn. 38, 297\u2013316 (1998).","journal-title":"Brain Cogn."},{"key":"BFnrneurol200962_CR54","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000212871","volume":"33","author":"W Birkmayer","year":"1987","unstructured":"Birkmayer, W. & Birkmayer, J. D. Dopamine action and disorders of neurotransmitter balance. Gerontology 33, 168\u2013171 (1987).","journal-title":"Gerontology"},{"key":"BFnrneurol200962_CR55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/archneur.1980.00500520053008","volume":"37","author":"BL Beasley","year":"1980","unstructured":"Beasley, B. L., Nutt, J. G., Davenport, R. W. & Chase, T. N. Treatment with tryptophan of levodopa-associated psychiatric disturbances. Arch. Neurol. 37, 155\u2013156 (1980).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol200962_CR56","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000212220","volume":"23","author":"JM Rabey","year":"1977","unstructured":"Rabey, J. M., Vardi, J., Askenazi, J. J. & Streifler, M. L-tryptophan administration in L-dopa induced hallucinations in elderly Parkinsonian patients. Gerontology 23, 438\u2013444 (1977).","journal-title":"Gerontology"},{"key":"BFnrneurol200962_CR57","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1517\/14656560802532707","volume":"9","author":"A Abbas","year":"2008","unstructured":"Abbas, A. & Roth, B. L. Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders. Expert Opin. Pharmacother. 9, 3251\u20133259 (2008).","journal-title":"Expert Opin. Pharmacother."},{"key":"BFnrneurol200962_CR58","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/mds.20263","volume":"20","author":"AD de Maindreville","year":"2005","unstructured":"de Maindreville, A. D., F\u00e9nelon, G. & Mahieux, F. Hallucinations in Parkinson's disease: a follow-up study. Mov. Disord. 20, 212\u2013217 (2005).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR59","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/mds.21298","volume":"22","author":"A Nebe","year":"2007","unstructured":"Nebe, A. & Ebersbach, G. Selective diplopia in Parkinson's disease: a special subtype of visual hallucination? Mov. Disord. 22, 1175\u20131178 (2007).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR60","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/0891988705284739","volume":"19","author":"H Matsui","year":"2006","unstructured":"Matsui, H. et al. Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease. J. Geriatr. Psychiatry Neurol. 19, 36\u201340 (2006).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"BFnrneurol200962_CR61","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1212\/01.WNL.0000145764.70698.4E","volume":"63","author":"UP Mosimann","year":"2004","unstructured":"Mosimann, U. P. et al. Visual perception in Parkinson disease dementia and Lewy body dementia. Neurology 63, 2091\u20132096 (2004).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR62","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1001\/archneur.59.8.1249","volume":"59","author":"NJ Diederich","year":"2002","unstructured":"Diederich, N. J., Raman, R., Leurgans, S. & Goetz, C. G. Progressive worsening of spatial and chromatic processing deficits in Parkinson's disease. Arch. Neurol. 59, 1249\u20131252 (2002).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol200962_CR63","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1093\/brain\/awh581","volume":"128","author":"MF Silva","year":"2005","unstructured":"Silva, M. F. et al. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease. Brain 128, 2260\u20132271 (2005).","journal-title":"Brain"},{"key":"BFnrneurol200962_CR64","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1212\/01.wnl.0000203648.80727.5b","volume":"66","author":"RB Postuma","year":"2006","unstructured":"Postuma, R. B., Lang, A. E., Massicotte-Marquez, J. & Montplaisir, J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 66, 845\u2013851 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR65","first-page":"289","volume":"21","author":"NJ Diederich","year":"1998","unstructured":"Diederich, N. J. et al. Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin. Neuropharmacol. 21, 289\u2013295 (1998).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol200962_CR66","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/S0042-6989(00)00036-5","volume":"40","author":"B Wink","year":"2000","unstructured":"Wink, B. & Harris, J. A model of the parkinsonian visual system: support for the dark adaptation hypothesis. Vision Res. 40, 1937\u20131946 (2000).","journal-title":"Vision Res."},{"key":"BFnrneurol200962_CR67","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/archneur.1997.00550190005001","volume":"54","author":"FE Lepore","year":"1997","unstructured":"Lepore, F. E. Visual loss as a causative factor in visual hallucinations associated with Parkinson's disease. Arch. Neurol. 54, 799 (1997).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol200962_CR68","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1176\/ajp.122.8.920","volume":"122","author":"N Rosenzweig","year":"1966","unstructured":"Rosenzweig, N. & Gardner, N. The role of input relevance in sensory isolation. Am. J. Psychiatr. 122, 920\u2013928 (1966).","journal-title":"Am. J. Psychiatr."},{"key":"BFnrneurol200962_CR69","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0028-3932(02)00182-3","volume":"41","author":"J Barnes","year":"2003","unstructured":"Barnes, J., Boubert, L., Harris, J., Lee, A. & David, A. S. Reality monitoring and visual hallucinations in Parkinson's disease. Neuropsychologia 41, 565\u2013574 (2003).","journal-title":"Neuropsychologia"},{"key":"BFnrneurol200962_CR70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuropsychologia.2006.04.016","volume":"45","author":"AD Lawrence","year":"2007","unstructured":"Lawrence, A. D., Goerendt, I. K. & Brooks, D. J. Impaired recognition of facial expressions of anger in Parkinson's disease patients acutely withdrawn from dopamine replacement therapy. Neuropsychologia 45, 65\u201374 (2007).","journal-title":"Neuropsychologia"},{"key":"BFnrneurol200962_CR71","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0028-3932(02)00295-6","volume":"41","author":"R Sprengelmeyer","year":"2003","unstructured":"Sprengelmeyer, R. et al. Facial expression recognition in people with medicated and unmedicated Parkinson's disease. Neuropsychologia 41, 1047\u20131057 (2003).","journal-title":"Neuropsychologia"},{"issue":"Suppl. 2","key":"BFnrneurol200962_CR72","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1007\/s100720200085","volume":"23","author":"M Onofrj","year":"2002","unstructured":"Onofrj, M. et al. Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up. Neurol. Sci. 23 (Suppl. 2), S91\u2013S94 (2002).","journal-title":"Neurol. Sci."},{"key":"BFnrneurol200962_CR73","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.20958","volume":"60","author":"EY Uc","year":"2006","unstructured":"Uc, E. Y. et al. Impaired visual search in drivers with Parkinson's disease. Ann. Neurol. 60, 407\u2013413 (2006).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol200962_CR74","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/brain\/awm178","volume":"130","author":"EY Uc","year":"2007","unstructured":"Uc, E. Y. et al. Impaired navigation in drivers with Parkinson's disease. Brain 130, 2433\u20132440 (2007).","journal-title":"Brain"},{"key":"BFnrneurol200962_CR75","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00002826-198205020-00003","volume":"5","author":"PA Nausieda","year":"1982","unstructured":"Nausieda, P. A., Weiner, W. J., Kaplan, L. R., Weber, S. & Klawans, H. L. Sleep disruption and psychosis in chronic levodopa therapy. Clin. Neuropharmacol. 5, 183\u2013194 (1982).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol200962_CR76","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/mds.20582","volume":"20","author":"C Pacchetti","year":"2005","unstructured":"Pacchetti, C. et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov. Disord. 20, 1439\u20131448 (2005).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR77","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.sleep.2007.06.013","volume":"4","author":"M Terzaghi","year":"2008","unstructured":"Terzaghi, M. et al. Cognitive performance in REM sleep behavior disorder: a possible early marker of neurodegenerative disease? Sleep Med. 4, 343\u2013351 (2008).","journal-title":"Sleep Med."},{"key":"BFnrneurol200962_CR78","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1212\/01.wnl.0000278114.14096.74","volume":"69","author":"M Vendette","year":"2007","unstructured":"Vendette, M. et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology 69, 1843\u20131849 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR79","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ana.410340514","volume":"34","author":"CL Comella","year":"1993","unstructured":"Comella, C. L., Tanner, C. M. & Ristanovic, R. K. Polysomnographic sleep measures in Parkinson's disease patients with treatment- induced hallucinations. Ann. Neurol. 34, 710\u2013714 (1993).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol200962_CR80","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/mds.10439","volume":"18","author":"T Nomura","year":"2003","unstructured":"Nomura, T. et al. Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease. Mov. Disord. 18, 812\u2013817 (2003).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR81","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1212\/WNL.55.2.281","volume":"55","author":"I Arnulf","year":"2000","unstructured":"Arnulf, I. et al. Hallucinations, REM sleep, and Parkinson's disease. Neurology 55, 281\u2013288 (2000).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR82","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mds.20308","volume":"20","author":"NJ Diederich","year":"2005","unstructured":"Diederich, N. J., Goetz, C. G. & Stebbins, G. T. Repeated visual hallucinations in Parkinson's disease as disturbed external\/internal perceptions: focused review and a new integrative model. Mov. Disord. 20, 130\u2013140 (2005).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR83","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1212\/01.wnl.0000233926.47469.73","volume":"67","author":"JF Gagnon","year":"2006","unstructured":"Gagnon, J. F., Postuma, R. B. & Montplaisir, J. Update on the pharmacology of REM sleep behavior disorder. Neurology 67, 742\u2013747 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR84","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol200962_CR85","first-page":"1","volume":"53","author":"K Jellinger","year":"1990","unstructured":"Jellinger, K. New developments in the pathology of Parkinson's disease. Adv. Neurol. 53, 1\u201316 (1990).","journal-title":"Adv. Neurol."},{"key":"BFnrneurol200962_CR86","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/brain\/awm090","volume":"130","author":"R Fronczek","year":"2007","unstructured":"Fronczek, R. et al. Hypocretin (orexin) loss in Parkinson's disease. Brain 130, 1577\u20131585 (2007).","journal-title":"Brain"},{"key":"BFnrneurol200962_CR87","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000026657","volume":"41","author":"S Lal","year":"2000","unstructured":"Lal, S., Tesfaye, Y., Thavundayil, J. X., Skorzewska, A. & Schwartz, G. Effect of time-of-day on the yawning response to apomorphine in normal subjects. Neuropsychobiology 41, 178\u2013180 (2000).","journal-title":"Neuropsychobiology"},{"key":"BFnrneurol200962_CR88","doi-asserted-by":"publisher","first-page":"10577","DOI":"10.1523\/JNEUROSCI.1767-06.2006","volume":"26","author":"K Dzirasa","year":"2006","unstructured":"Dzirasa, K. et al. Dopaminergic control of sleep-wake states. J. Neurosci. 26, 10577\u201310589 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrneurol200962_CR89","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00002826-200207000-00002","volume":"25","author":"B Bruguerolle","year":"2002","unstructured":"Bruguerolle, B. & Simon, N. Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin. Neuropharmacol. 25, 194\u2013201 (2002).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol200962_CR90","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/mds.22057","volume":"23","author":"DL Whitehead","year":"2008","unstructured":"Whitehead, D. L., Davies, A. D., Playfer, J. R. & Turnbull, C. J. Circadian rest-activity rhythm is altered in Parkinson's disease patients with hallucinations. Mov. Disord. 23, 1137\u20131145 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR91","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1212\/01.WNL.0000038351.32678.4A","volume":"59","author":"R Manni","year":"2002","unstructured":"Manni, R. et al. Hallucinations and sleep-wake cycle in PD: a 24-hour continuous polysomnographic study. Neurology 59, 1979\u20131981 (2002).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR92","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/gps.1339","volume":"20","author":"D Grossi","year":"2005","unstructured":"Grossi, D. et al. Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients. Int. J. Geriatr. Psychiatry 20, 668\u2013673 (2005).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"BFnrneurol200962_CR93","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1002\/mds.21746","volume":"22","author":"G Santangelo","year":"2007","unstructured":"Santangelo, G. et al. A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. Mov. Disord. 22, 2418\u20132425 (2007).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR94","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/mds.20965","volume":"21","author":"B Ram\u00edrez-Ruiz","year":"2006","unstructured":"Ram\u00edrez-Ruiz, B., Junqu\u00e9, C., Mart\u00ed, M. J., Valldeoriola, F. & Tolosa, E. Neuropsychological deficits in Parkinson's disease patients with visual hallucinations. Mov. Disord. 21, 1483\u20131487 (2006).","journal-title":"Mov. Disord."},{"issue":"Suppl. 16","key":"BFnrneurol200962_CR95","first-page":"S166","volume":"22","author":"DL Whitehead","year":"2007","unstructured":"Whitehead, D. L., Davies, A. D. M, Downes, J. J., Turnbull, C. J. & Playfer, J. R. Neuropsychological predictors of hallucinations in Parkinson's disease: Cognitive and perceptual biases [abstract 538]. Mov. Disord. 22 (Suppl. 16), S166 (2007).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR96","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1002\/mds.22270","volume":"23","author":"AM Meppelink","year":"2008","unstructured":"Meppelink, A. M., Koerts, J., Borg, M., Leenders, K. L. & van Laar, T. Visual object recognition and attention in Parkinson's disease patients with visual hallucinations. Mov. Disord. 23, 1906\u20131912 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR97","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1212\/01.WNL.0000036908.39696.FD","volume":"59","author":"CG Ballard","year":"2002","unstructured":"Ballard, C. G. et al. Fluctuations in attention. PD dementia vs DLB with parkinsonism. Neurology 59, 1714\u20131720 (2002).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR98","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1474-4422(05)70146-0","volume":"4","author":"DR Williams","year":"2005","unstructured":"Williams, D. R. & Lees, A. J. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol. 4, 605\u2013610 (2005).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol200962_CR99","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00415-005-0840-x","volume":"252","author":"S Papapetropoulos","year":"2005","unstructured":"Papapetropoulos, S., Argyriou, A. A. & Ellul, J. Factors associated with drug-induced visual hallucinations in Parkinson's disease. J. Neurol. 252, 1223\u20131228 (2005).","journal-title":"J. Neurol."},{"key":"BFnrneurol200962_CR100","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000100850","volume":"23","author":"B Ramirez-Ruiz","year":"2007","unstructured":"Ramirez-Ruiz, B., Junque, C., Marti, M. J., Valldeoriola, F. & Tolosa, E. Cognitive changes in Parkinson's disease patients with visual hallucinations. Dement. Geriatr. Cogn. Disord. 23, 281\u2013288 (2007).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"BFnrneurol200962_CR101","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/mds.20701","volume":"21","author":"CG Goetz","year":"2006","unstructured":"Goetz, C. G., Wuu, J., Curgian, L. & Leurgans, S. Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients. Mov. Disord. 21, 267\u2013270 (2006).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR102","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00002826-198506000-00015","volume":"8","author":"R Sandyk","year":"1985","unstructured":"Sandyk, R. & Gillman, M. A. Depression as a cause of hallucinations in Parkinson's disease. Clin. Neuropharmacol. 8, 199\u2013200 (1985).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol200962_CR103","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/gps.389","volume":"16","author":"D Aarsland","year":"2001","unstructured":"Aarsland, D., Ballard, C., Larsen, J. P. & McKeith, I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int. J. Geriatr. Psychiatry 16, 528\u2013536 (2001).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"BFnrneurol200962_CR104","first-page":"226","volume":"22","author":"R de la Fuente-Fernandez","year":"1999","unstructured":"de la Fuente-Fernandez, R., N\u00fa\u00f1ez, M. A. & L\u00f3pez, E. The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease. Clin. Neuropharmacol. 22, 226\u2013230 (1999).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol200962_CR105","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1600-0404.2005.00535.x","volume":"113","author":"B Feldman","year":"2006","unstructured":"Feldman, B., Chapman, J. & Korczyn, A. D. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease. Acta Neurol. Scand. 113, 14\u201317 (2006).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol200962_CR106","first-page":"1280","volume":"61","author":"JG Goldman","year":"2004","unstructured":"Goldman, J. G., Goetz, C. G., Berry-Kravis, E., Leurgans, S. & Zhou, L. Genetic plymorphisms in Parkinson's disease subjects with and without hallucinations. Arch. Neurol. 61, 1280\u20131284 (2004).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol200962_CR107","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/archneur.58.2.209","volume":"58","author":"CG Goetz","year":"2001","unstructured":"Goetz, C. G. et al. Genetic variation analysis in Parkinson disease patients with and without hallucinations: case-control study. Arch. Neurol. 58, 209\u2013213 (2001).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol200962_CR108","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/mds.10409","volume":"18","author":"M Onofrj","year":"2003","unstructured":"Onofrj, M. et al. HLA typing does not predict REM sleep behavior disorder and hallucinations in Parkinson's disease. Mov. Disord. 18, 337\u2013340 (2003).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR109","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neulet.2007.06.028","volume":"422","author":"L Kiferle","year":"2007","unstructured":"Kiferle, L. et al. Visual hallucinations in Parkinson's disease are not influenced by polymorphismas of serotonin 5-HT2A receptor and transporter genes. Neurosci. Lett. 422, 228\u2013231 (2007).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol200962_CR110","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF02307822","volume":"10","author":"J Nguyen-Legros","year":"1988","unstructured":"Nguyen-Legros, J. Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease. Surg. Radiol. Anat. 10, 137\u2013144 (1988).","journal-title":"Surg. Radiol. Anat."},{"key":"BFnrneurol200962_CR111","first-page":"2473","volume":"31","author":"C Harnois","year":"1990","unstructured":"Harnois, C. & Di Paolo, T. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest. Ophtalmol. Vis. Sci. 31, 2473\u20132475 (1990).","journal-title":"Invest. Ophtalmol. Vis. Sci."},{"key":"BFnrneurol200962_CR112","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1016\/S0042-6989(97)00129-6","volume":"37","author":"MB Djamgoz","year":"1997","unstructured":"Djamgoz, M. B., Hankins, M. W., Hirano, J. & Archer, S. N. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res. 37, 3509\u20133529 (1997).","journal-title":"Vision Res."},{"key":"BFnrneurol200962_CR113","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.visres.2004.06.009","volume":"44","author":"R Inzelberg","year":"2004","unstructured":"Inzelberg, R., Ramirez, J. A., Nisipeanu, P. & Ophir, A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res. 44, 2793\u20132797 (2004).","journal-title":"Vision Res."},{"key":"BFnrneurol200962_CR114","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ana.10730","volume":"54","author":"CA Maurage","year":"2003","unstructured":"Maurage, C. A., Ruchoux, M. M., de Vos, R., Surguchov, A. & Destee, A. Retinal involvement in dementia with Lewy bodies: a clue to hallucinations? Ann. Neurol. 54, 542\u2013547 (2003).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol200962_CR115","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/01.wnl.0000178896.44905.33","volume":"65","author":"D Devos","year":"2005","unstructured":"Devos, D. et al. ERG and anatomical abnormalities suggesting retinopathy in dementia with Lewy bodies. Neurology 65, 1107\u20131110 (2005).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR116","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1468-1331.2007.01768.x","volume":"14","author":"B Ram\u00edrez-Ruiz","year":"2007","unstructured":"Ram\u00edrez-Ruiz, B. et al. Cerebral atrophy in Parkinson's disease patients with visual hallucinations. Eur. J. Neurol. 14, 750\u2013756 (2007).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol200962_CR117","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.parkreldis.2005.10.005","volume":"12","author":"S Papapetropoulos","year":"2006","unstructured":"Papapetropoulos, S., McCorquodale, D. S., Gonzalez, J., Jean-Gilles, L. & Mash, D. C. Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations. Parkinsonism Relat. Disord. 12, 253\u2013256 (2006).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol200962_CR118","volume-title":"An Introduction to Visual Perception","author":"R Snowden","year":"2006","unstructured":"Snowden, R., Thompson, P. & Troscianko, T. Basic Vision. An Introduction to Visual Perception (Oxford University Press, Oxford, 2006)."},{"key":"BFnrneurol200962_CR119","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1212\/01.WNL.0000141853.27081.BD","volume":"63","author":"GT Stebbins","year":"2004","unstructured":"Stebbins G. T. et al. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 63, 1409\u20131416 (2004).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR120","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1002\/mds.22258","volume":"23","author":"B Ramirez-Ruiz","year":"2008","unstructured":"Ramirez-Ruiz, B. et al. Brain response to complex visual stimuli in Parkinson's patients with hallucinations: a functional magnetic resonance imaging study. Mov. Disord. 23, 2335\u20132343 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR121","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/mds.20129","volume":"19","author":"A Nagano-Saito","year":"2004","unstructured":"Nagano-Saito, A. et al. Visual hallucination in Parkinson's disease with FDG PET. Mov. Disord. 19, 801\u2013806 (2004).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR122","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1212\/01.wnl.0000187116.13370.e0","volume":"65","author":"N Oishi","year":"2005","unstructured":"Oishi, N. et al. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology 65, 1708\u20131715 (2005).","journal-title":"Neurology"},{"key":"BFnrneurol200962_CR123","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/S0140-6736(96)90869-7","volume":"347","author":"RJ Teunisse","year":"1996","unstructured":"Teunisse, R. J., Cruysberg, J. R., Hoefnagels, W. H., Verbeek, A. L. & Zitman, F. G. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 347, 794\u2013797 (1996).","journal-title":"Lancet"},{"key":"BFnrneurol200962_CR124","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11920-005-0050-3","volume":"7","author":"DH Ffytche","year":"2005","unstructured":"Ffytche, D. H. Visual hallucinations and the Charles Bonnet syndrome. Curr. Psychiatry Rep. 7, 168\u2013179 (2005).","journal-title":"Curr. Psychiatry Rep."},{"key":"BFnrneurol200962_CR125","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/3738","volume":"1","author":"DH Ffytche","year":"1998","unstructured":"Ffytche, D. H. et al. The anatomy of conscious vision: an fMRI study of visual hallucinations. Nat. Neurosci. 1, 738\u2013742 (1998).","journal-title":"Nat. Neurosci."},{"key":"BFnrneurol200962_CR126","first-page":"1359","volume":"38","author":"J Lhermitte","year":"1922","unstructured":"Lhermitte, J. Syndrome de la calotte du p\u00e9doncule c\u00e9r\u00e9bral. Les troubles psycho-sensoriels dans les l\u00e9sions du m\u00e9senc\u00e9phale [French]. Rev. Neurol. (Paris) 38, 1359\u20131365 (1922).","journal-title":"Rev. Neurol. (Paris)"},{"key":"BFnrneurol200962_CR127","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrn2536","volume":"10","author":"PC Fletcher","year":"2009","unstructured":"Fletcher, P. C. & Frith, C. D. Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia. Nat. Rev. Neurosci. 10, 48\u201358 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrneurol200962_CR128","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1017\/S0140525X05000130","volume":"28","author":"D Collerton","year":"2005","unstructured":"Collerton, D., Perry, E. & McKeith, I. Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav. Brain Sci. 28, 737\u2013757 (2005).","journal-title":"Behav. Brain Sci."},{"key":"BFnrneurol200962_CR129","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrn915","volume":"3","author":"JA Hobson","year":"2002","unstructured":"Hobson, J. A. & Pace-Schott, E. F. The cognitive neuroscience of sleep: neuronal systems, conciousness and learning. Nat. Rev. Neurosci. 3, 679\u2013693 (2002).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrneurol200962_CR130","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/mds.10450","volume":"18","author":"NJ Diederich","year":"2003","unstructured":"Diederich, N. J., Pieri, V. & Goetz, C. G. Coping strategies for visual hallucinations in Parkinson's disease. Mov. Disord. 18, 831\u2013832 (2003).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR131","doi-asserted-by":"crossref","unstructured":"[No authors listed] Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. The Parkinson Study Group. N. Engl. J. Med. 340, 757\u2013763 (1999).","DOI":"10.1056\/NEJM199903113401003"},{"key":"BFnrneurol200962_CR132","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00002826-200301000-00003","volume":"26","author":"C Klein","year":"2003","unstructured":"Klein, C., Gordon, J., Pollak, L. & Rabey, J. M. Clozapine in Parkinson's disease psychosis: 5-year follow-up review. Clin. Neuropharmacol. 26, 8\u201311 (2003).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol200962_CR133","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/jnnp.2003.029868","volume":"75","author":"P Pollak","year":"2004","unstructured":"Pollak, P. et al. Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up. J. Neurol. Neurosurg. Psychiatry 75, 689\u2013695 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200962_CR134","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/mds.20491","volume":"20","author":"WG Ondo","year":"2005","unstructured":"Ondo, W. G., Levy, J. K., Vuong, K. D., Hunter, C. & Jankovic, J. Olanzapine for the treatment of dopaminergic induced hallucinations. Mov. Disord. 20, 1031\u20131035 (2005).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR135","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.21116","volume":"22","author":"JM Rabey","year":"2007","unstructured":"Rabey, J. M., Prokhorov, T., Miniovitz, A., Dobronevsky, E. & Klein, C. Effect of quetiapine in psychotic PD patients: a double blind labeled study of 3 months' duration. Mov. Disord. 22, 313\u2013318 (2007).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR136","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/01.WNF.0000236769.31279.19","volume":"29","author":"D Merims","year":"2006","unstructured":"Merims, D., Balas, M., Peretz, C., Shabtai, H. & Giladi, N. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis. Clin. Neuropharmacol. 29, 331\u2013337 (2006).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol200962_CR137","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/mds.10620","volume":"19","author":"JL Juncos","year":"2004","unstructured":"Juncos, J. L. et al. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease. Mov. Disord. 19, 29\u201335 (2004).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR138","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1503\/cmaj.050478","volume":"173","author":"S Singh","year":"2005","unstructured":"Singh, S. & Wooltorton, E. Increased mortality among elderly patients with dementia using atypical antipsychotics. CMAJ 173, 252 (2005).","journal-title":"CMAJ"},{"key":"BFnrneurol200962_CR139","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3928\/02793695-20080401-09a","volume":"46","author":"RH Howland","year":"2008","unstructured":"Howland, R. H. Risks and benefits of antipsychotic drugs in elderly patients with dementia. J. Psychosoc. Nurs. Ment. Health Serv. 46, 19\u201323 (2008).","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"key":"BFnrneurol200962_CR140","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/mds.22132","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G., Fan, W. & Leurgans, S. Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: positive impact on long-term worsening. Mov. Disord. 23, 1541\u20131545 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR141","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/0891988703256054","volume":"16","author":"A Kurita","year":"2003","unstructured":"Kurita, A., Ochiai, Y., Kono, Y., Suzuki, M. & Inoue, K. The beneficial effect of donepezil on visual hallucinations in three patients with Parkinson's disease. J. Geriatr. Psychiatry Neurol. 16, 184\u2013188 (2003).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"BFnrneurol200962_CR142","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/mds.21077","volume":"21","author":"D Burn","year":"2006","unstructured":"Burn, D. et al. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Mov. Disord. 21, 1899\u20131907 (2006).","journal-title":"Mov. Disord."},{"key":"BFnrneurol200962_CR143","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3233\/JAD-2007-11412","volume":"11","author":"M Emre","year":"2007","unstructured":"Emre, M., Cummings, J. L. & Lane, R. M. Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences. J. Alzheimers Dis. 11, 509\u2013514 (2007).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol200962_CR144","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ncpneuro0471","volume":"3","author":"CH Williams-Gray","year":"2007","unstructured":"Williams-Gray, C. H. & Barker, R. A. Visual hallucinations predict increased benefits from rivastigmine in Parkinson's disease dementia. Nat. Clin. Pract. Neurol. 3, 250\u2013251 (2007).","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"BFnrneurol200962_CR145","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/00002826-200403000-00009","volume":"27","author":"V Voon","year":"2004","unstructured":"Voon, V. & Lang, A. E. Antidepressants in the treatment of psychosis with comorbid depression in Parkinson disease. Clin. Neuropharmacol. 27, 90\u201392 (2004).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol200962_CR146","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.pnpbp.2006.06.016","volume":"31","author":"G Meco","year":"2007","unstructured":"Meco, G. & Bernardi, S. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease. Prog. Neuropsycholpharmacol. Biol. Psychiatry 31, 311\u2013331 (2007).","journal-title":"Prog. Neuropsycholpharmacol. Biol. Psychiatry"},{"key":"BFnrneurol200962_CR147","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1440-1819.2007.01732.x","volume":"61","author":"N Yamamoto","year":"2007","unstructured":"Yamamoto, N., Oda, T. & Inada, T. Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam. Psychiatry Clin. Neurosci. 61, 691\u2013694 (2007).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"BFnrneurol200962_CR148","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00005053-198202000-00010","volume":"170","author":"MC White","year":"1982","unstructured":"White, M. C., Sliverman, J. J. & Harbison, J. W. Psychosis associated with clonazepam therapy for blepharospasm. J. Nerv. Ment. Dis. 170, 117\u2013119 (1982).","journal-title":"J. Nerv. Ment. Dis."},{"key":"BFnrneurol200962_CR149","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/jnnp.42.8.724","volume":"42","author":"VA Sironi","year":"1979","unstructured":"Sironi, V. A., Franzini, A., Ravagnati, L. & Marossero, F. Interinctal acute psychosis in temporal lobe epilepsy during withdrawal of anticonvulsant therapy. J. Neurol. Neurosurg. Psychiatry 42, 724\u2013730 (1979).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol200962_CR150","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/07420520701420717","volume":"24","author":"GL Willis","year":"2007","unstructured":"Willis, G. L. & Turner, E. J. Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study. Chronobiol. Int. 24, 521\u2013537 (2007).","journal-title":"Chronobiol. Int."},{"key":"BFnrneurol200962_CR151","volume-title":"Parkinson's Disease. A Guide for Patient and Family","author":"RC Duvoisin","year":"1991","unstructured":"Duvoisin, R. C. Parkinson's Disease. A Guide for Patient and Family (Raven, New York, 1991)."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2009.62.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2009.62","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2009.62.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T22:41:55Z","timestamp":1739140915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2009.62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":151,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BFnrneurol200962"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2009.62","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}